Meta-analysis on the efficacy and safety of rituximab versus tacrolimus for nephrotic syndrome in the paediatric age group.

ABSTRACT:

SUBMITTER: Rehan ST 

PROVIDER: S-EPMC10768748 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature